Godi Sudhakar
Overview
Explore the profile of Godi Sudhakar including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
66
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sharma Y, Sridevi P, Bhat D, Surti S, Sarmah J, Sudhakar G, et al.
Int J Health Plann Manage
. 2025 Mar;
PMID: 40070016
This study addresses significant healthcare access challenges faced by India's 104 million-strong tribal population, who are among the most disadvantaged and typically live in hilly rural and remote areas with...
2.
Sharma Y, Bhat D, Sridevi P, Surti S, Ranjit M, Sarmah J, et al.
Blood Cells Mol Dis
. 2024 Jul;
109:102873.
PMID: 39024737
Background: Sickle cell disease (SCD) registries provide crucial real-world data on demographics, epidemiology, healthcare, patient outcomes, and treatment efficacy. This paper presents findings from the Indian SCD Registry (ISCDR) on...
3.
Babu B, Sharma Y, Sridevi P, Surti S, Bhat D, Ranjit M, et al.
Hemoglobin
. 2024 Jan;
47(6):227-236.
PMID: 38189147
Sickle cell disease (SCD) affects 5% of the global population, with over 300,000 infants born yearly. In India, 73% of those with the sickle hemoglobin gene belong to indigenous tribes...
4.
Babu B, Sharma Y, Surti S, Bhat D, Sridevi P, Ranjit M, et al.
Int J Health Plann Manage
. 2023 Jun;
38(5):1483-1494.
PMID: 37340519
In India, sickle cell disease (SCD) predominantly occurs in indigenous (tribal) people, who are about 104 million. However, screening and diagnosis seldom happen. This situation necessitates developing a comprehensive SCD...
5.
Babu B, Sridevi P, Surti S, Bhat D, Sarmah J, Sudhakar G, et al.
J Community Genet
. 2022 Oct;
13(6):597-603.
PMID: 36227533
Sickle cell disease (SCD) is a progressively debilitating genetic disease, and India is the second most affected nation in the prevalence of births with SCD. This SCD prevalence is high...
6.
Babu B, Kusuma Y, Sivakami M, Lal D, Geddam J, Khanna A, et al.
J Migr Health
. 2022 Sep;
6:100130.
PMID: 36110500
Background: Disparities in healthcare access to internal migrants exist, and the gaps may widen further if appropriate steps are not taken. Innovative approaches are needed to better align the healthcare...
7.
Babu B, Sharma Y, Sridevi P, Surti S, Ranjit M, Bhat D, et al.
J Med Screen
. 2022 Aug;
30(1):28-35.
PMID: 36036388
Objective: To describe the development and implementation of a population-based screening programme for sickle cell disease (SCD) implemented in 12 SCD-endemic and tribal-dominated primary/community health centres (PHCs/CHCs) across six districts...
8.
Babu B, Sridevi P, Surti S, Ranjit M, Bhat D, Sarmah J, et al.
J Community Genet
. 2022 Feb;
13(3):329-338.
PMID: 35103923
This study reports the extent of sickle cell disease (SCD)-related knowledge and management practices of peripheral health workers located in tribal areas of India. This formative qualitative study used a...
9.
Babu B, Sridevi P, Surti S, Ranjit M, Bhat D, Sarmah J, et al.
Trans R Soc Trop Med Hyg
. 2021 May;
115(12):1434-1444.
PMID: 34037804
Background: Sickle cell disease (SCD) is a serious public health problem, with >300 000 affected births worldwide each year. About 73% of the SCD-affected people in India belong to the...
10.
Babu B, Sridevi P, Surti S, Ranjit M, Bhat D, Sarmah J, et al.
Pediatr Blood Cancer
. 2021 Feb;
68(6):e28911.
PMID: 33522713
No abstract available.